356 related articles for article (PubMed ID: 15569507)
1. [Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method].
Hong F; Jin TY; Zhang AH
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):374-8. PubMed ID: 15569507
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of cadmium and arsenic interactions.
Nordberg GF; Jin T; Hong F; Zhang A; Buchet JP; Bernard A
Toxicol Appl Pharmacol; 2005 Aug; 206(2):191-7. PubMed ID: 15967208
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between plasma anti-metallothionein antibody and renal dysfunction in cadmium exposed workers].
Chen L; Jin TY; Chang XL; Lei LJ; Zhou YF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):7-11. PubMed ID: 16600085
[TBL] [Abstract][Full Text] [Related]
4. Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China.
Chen L; Jin T; Huang B; Nordberg G; Nordberg M
Toxicol Appl Pharmacol; 2006 Aug; 215(1):93-9. PubMed ID: 16510161
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population.
Hong F; Jin T; Zhang A
Biometals; 2004 Oct; 17(5):573-80. PubMed ID: 15688868
[TBL] [Abstract][Full Text] [Related]
6. Estimation of benchmark dose for pancreatic damage in cadmium-exposed smelters.
Lei LJ; Chen L; Jin TY; Nordberg M; Chang XL
Toxicol Sci; 2007 May; 97(1):189-95. PubMed ID: 17303580
[TBL] [Abstract][Full Text] [Related]
7. Estimation of benchmark dose for renal dysfunction in a cadmium non-polluted area in Japan.
Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
J Appl Toxicol; 2006; 26(4):351-5. PubMed ID: 16791912
[TBL] [Abstract][Full Text] [Related]
8. [Application of Benchmark dose (BMD) in estimating biological exposure limit (BEL)].
Shao B; Jin TY; Qian HL; Wu XW; Kong QH; Ye TT
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):20-2. PubMed ID: 16600088
[TBL] [Abstract][Full Text] [Related]
9. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.
Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
Environ Res; 2006 Jul; 101(3):401-6. PubMed ID: 16436274
[TBL] [Abstract][Full Text] [Related]
10. [Renal dysfunction in workers exposed to arsenic and cadmium].
Hong F; Jin TY; Lu GD; Yin ZY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Dec; 21(6):432-6. PubMed ID: 14761355
[TBL] [Abstract][Full Text] [Related]
11. [Application of benchmark dose (BMD) in a bone-effect study on a general population environmentally exposed to cadmium].
Qian HL; Jin TY; Kong QH; Wang HF; Zhu GY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):23-6. PubMed ID: 16600089
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the benchmark dose of urinary cadmium as the reference level for renal dysfunction: a large sample study in five cadmium polluted areas in China.
Ke S; Cheng XY; Zhang JY; Jia WJ; Li H; Luo HF; Ge PH; Liu ZM; Wang HM; He JS; Chen ZN
BMC Public Health; 2015 Jul; 15():656. PubMed ID: 26169263
[TBL] [Abstract][Full Text] [Related]
13. Estimation of benchmark dose for bone damage and renal dysfunction in a Chinese male population occupationally exposed to lead.
Sun Y; Sun D; Zhou Z; Zhu G; Lei L; Zhang H; Chang X; Jin T
Ann Occup Hyg; 2008 Aug; 52(6):527-33. PubMed ID: 18567606
[TBL] [Abstract][Full Text] [Related]
14. Reassessment of the threshold of urinary cadmium by using hybrid approach in a cadmium non-polluted area in Japan.
Suwazono Y; Nogawa K; Uetani M; Kido T; Nakagawa H
Int J Hyg Environ Health; 2011 Mar; 214(2):175-8. PubMed ID: 20889376
[TBL] [Abstract][Full Text] [Related]
15. Effects of low-dose cadmium exposure on biological examinations.
Nakadaira H; Nishi S
Sci Total Environ; 2003 Jun; 308(1-3):49-62. PubMed ID: 12738200
[TBL] [Abstract][Full Text] [Related]
16. Benchmark dose approach for renal dysfunction in workers exposed to lead.
Lin T; Tai-Yi J
Environ Toxicol; 2007 Jun; 22(3):229-33. PubMed ID: 17497640
[TBL] [Abstract][Full Text] [Related]
17. Application of the Benchmark Dose (BMD) Method to Identify Thresholds of Cadmium-Induced Renal Effects in Non-Polluted Areas in China.
Wang X; Wang Y; Feng L; Tong Y; Chen Z; Ying S; Chen T; Li T; Xia H; Jiang Z; Shang Q; Lou X; Lou J
PLoS One; 2016; 11(8):e0161240. PubMed ID: 27537182
[TBL] [Abstract][Full Text] [Related]
18. Renal effects evolution in a Chinese population after reduction of cadmium exposure in rice.
Wu X; Liang Y; Jin T; Ye T; Kong Q; Wang Z; Lei L; Bergdahl IA; Nordberg GF
Environ Res; 2008 Oct; 108(2):233-8. PubMed ID: 18692183
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors.
Nordberg GF; Jin T; Wu X; Lu J; Chen L; Lei L; Hong F; Nordberg M
Biochimie; 2009 Oct; 91(10):1282-5. PubMed ID: 19563860
[TBL] [Abstract][Full Text] [Related]
20. Estimation of benchmark doses as threshold levels of urinary cadmium, based on excretion of beta2-microglobulin in cadmium-polluted and non-polluted regions in Japan.
Kobayashi E; Suwazono Y; Dochi M; Honda R; Nishijo M; Kido T; Nakagawa H
Toxicol Lett; 2008 Jun; 179(2):108-12. PubMed ID: 18515022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
